Company intelligence / Profile preview

Gentle

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Gentle is a biotechnology company developing a "programmable biology" platform designed to streamline the engineering of biological systems. Founded by Ariel Weinberger, who previously founded a molecular biology software company also named Gentle (acquired by Benchling), the company aims to build the foundational "operating system" for biology. Gentle leverages advanced genomics, synthetic biology, and software engineering to enable more predictable and scalable biological design and experimentation. The company is currently in an early/stealth stage, focusing on infrastructure that bridges the gap between digital design and physical biological execution.

Modalities: Synthetic biologyGenomics platform
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Gentle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gentle.

Explore the full profile